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Abstract. Ankyrins are a family of large, membrane- 
associated proteins that mediate the linkage of the 
cytoskeleton to a variety of membrane transport and 
receptor proteins. A repetitive 33-residue motif charac- 
teristic of domain I of ankyrin has also been identified 
in proteins involved with cell cycle control and develop- 
ment. We have cloned and characterized a novel 
ankyrin isoform, AnkG119 (GenBank accession No. 
U43965), from the human kidney which lacks part of 
this repetitive domain and associates in MDCK cells 
with [ME* spectrin and the Golgi apparatus, but not the 
plasma membrane. Sequence comparison reveals this 
ankyrin to be an alternative transcript of AnkG, a much 
larger ankyrin recently cloned from brain. AnkG119 has 
a predicted size of 119,201 D, and contains a 47-kD do- 
main I consisting of 13 ankyrin repeat units, a 67-kD 
domain II with a highly conserved spectrin-binding mo- 
tif, and a truncated 5-kD putative regulatory domain. 
An AnkGu9 cDNA probe hybridized to a 6.0-kb mes- 
sage in human and rat kidney, placenta, and skeletal 
muscle. An antibody raised to AnkG119 recognized an 
apparent ll6-kD peptide in rat kidney cortical tissue 
and MDCK cell lysates, and did not react with larger 
isoforms of ankyrin at 190 and 210 kD in these tissues, 
nor in bovine brain, nor with ankyrin from human 
erythrocytes. Ank6u 9 remains extractable in 0.5% Tri- 
ton X-100, and assumes a punctuate cytoplasmic distri- 
bution in mature MDCK cells, in contrast to the Triton- 
stable plasma membrane localization of all previously 
described renal ankyrins. AnkG119 immunoreactivity in 
subconfluent MDCK cells distributes with the Golgi 
complex in a pattern coincident with [3-COP and [3IE* 
spectrin immunoreactivity. A fusion peptide containing 
residues 669-860 of AnkG119 interacts with [3IE1 spec- 
trin in vitro with a Kd =  4.2 _+ 4.0 (__-2 SD) nM, and av- 
idly binds the [3 spectrin in MDCK cell lysates. Collec- 
tively, these data identify AnkGu9 as a novel small 
ankyrin that binds and colocalizes with I3IE* spectrin in 
the ER and Golgi apparatus, and possibly on a subset 
of endosomes during the early stages of polarity devel- 
opment. We hypothesize that Ank6119 and 13I spectrin 
form a vesicular Golgi-associated membrane skeleton, 
promote the organization of protein microdomains 
within the Golgi and trans-Golgi networks, and contrib- 
ute to polarized vesicle transport. 
NTERACTIONS between  integral  membrane  proteins 
and  the  underlying  spectrin-actin  cytoskeleton play 
key roles in activities such as cell motility, activation, 
proliferation, contact, and the maintenance of specialized 
membrane  domains  (Luna  and  Hitt,  1992; Bennett  and 
Gilligan, 1993; Devarajan and Morrow, 1996; Morrow et al., 
1996). Ankyrins are a family of large,  membrane-associ- 
ated proteins that have emerged as crucial adapter molecules 
mediating such linkages, since they possess recognition sites 
for various membrane proteins as well as for cytoskeletal 
elements (Bennett, 1992). Molecules using a 33-residue re- 
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petitive structure first identified in the 89-kD domain I of 
ankyrin  display  a  wide  tissue  distribution  (Bork,  1993; 
Chan  et  al.,  1993; Axton  et  al.,  1994; Diederich  et  al., 
1994), and tissue-specific isoforms may be present in all 
cells  (Lux  et  al.,  1990a).  Several  distinct  isoforms  of 
ankyrin  have  been  recognized  by  their  immunological 
properties. The isoform associated with the membranes of 
red  cells,  neuronal  cell  bodies,  and  dendrites  has  been 
termed AnkR. Antibodies to AnkR also cross-react with an 
ankyrin found in the basolateral membrane of polarized 
epithelial cells  (Davis et al.,  1989; Morrow et al.,  1989). 
AnkR is encoded by the ANK1 gene (Lux et al., 1990a,b), 
which transcribes mRNA species of 7 kb in erythrocytes 
(Lambert et al., 1990; Lux et al., 1990a) and 9 kb in brain 
(Lambert et al., 1990). AnkB is the major isoform in brain, 
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branes, as well as in a  variety of nonneuronal tissues in- 
cluding the kidney. It is the product of the ANK2 gene 
(Otto  et  al.,  1991). At  least  two  alternatively  spliced 
mRNA transcripts of 9 and 13 kb are generated from this 
gene (Kunimoto et al., 1991; Otto et al., 1991). AnkG is an 
immunologically distinct  isoform  found  at  the  plasma 
membrane at the nodes of Ranvier and at the axon initial 
segments (Kordeli et al., 1990, 1995; Kordeli and Bennett, 
1991). It is the product of the ANK3 gene (Peters et al., 
1995). Although two transcripts of the Ank  G gene (15 and 
10  kb)  are  neural-specific,  smaller,  alternatively spliced 
isoforms may be expressed in the kidney and lung (Kor- 
dell et al.,  1995; Peters et al.,  1995). In addition, a 72-kD 
truncated ankyrin that binds spectrin and is localized with 
the membrane protein GP85 has been detected immuno- 
logically in T lymphocytes; its gene of origin is unknown 
(Bourguignon et al., 1986). 
Such isoform diversity may be critical to maintain a spe- 
cific pattern of protein distribution in neurons and polar- 
ized epithelial cells such as those of the kidney tubules that 
directionally transport ions and nutrients. It is likely that 
such tissues harbor additional isoforms of ankyrin. Anti- 
bodies raised against AnkR recognize a 210-kD product in 
erythrocytes and  a  190-kD  polypeptide in kidney tissue 
(Davis et al., 1989; Morrow et al., 1991). The Ank  R from 
both sources binds spectrin and Na,K-ATPase (Devarajan 
et al.,  1994).  AnkR-deficient NB/NB  mice, however, ex- 
press  the  190-kD  renal ankyrin, indicating that it is  en- 
coded  by  a  gene  distinct  from ANK1,  presumably  an 
ANK3 gene (Bennett, 1992).  Antibodies to Ank  B cross- 
react with a  220-kD  peptide in kidney tissue, but AnkB 
eDNA probes hybridize only weakly to renal RNA (Otto 
et al., 1991), suggesting that the kidney Ank  B peptide may 
also be the product of a distinct gene. Finally, antibodies 
to Ank~ recognize polypeptides in the 190-72-kD range in 
rat kidney (Kordeli et al., I995), none of which have been 
further characterized. 
In this study, we describe the cDNA cloning, character- 
ization, and intracellular localization of a  small  ll9-kD 
ankyrin isoform (AnkGng) from kidney tissues. After this 
work was first submitted, a report describing Ank  C in the 
brain appeared  (Kordeli et  al.,  1995).  Comparison with 
that sequence reveals the ankyrin we have cloned to be an 
alternative transcript of the larger form that was identified 
in brain. Therefore, we now refer to this form as Ank~119, 
rather than AnkK, as had been previously reported in ab- 
stract form (Devarajan, P., A. Mann, T. Ardito, P. Stabach, 
M. Kashgarian, and J.S. Morrow. 1995. Mol. Biol. Cell. 6: 
269a) and in the initial version of this report. AnkG119 pos- 
sesses only part of the repeats domain characteristic of all 
previously described ankyrins, and also deletes almost the 
entire regulatory domain. AnkGl~9 is expressed in the kid- 
ney, placenta, and skeletal muscle, in MDCK cells (a col- 
lecting tubule line), and in cultured porcine proximal tu- 
bule  cells  (LLC-PK1).  The  distribution  of  this  small 
ankyrin in rat kidney cells  and in confluent MDCK and 
LLC-PK1 cells is cytoplasmic and Golgi associated, unlike 
the plasma membrane localization of all other previously 
described ankyrin isoforms. AnkG119 also specifically binds 
MDCK cell 13I~* spectrin  (erythroid-like) in vitro  with 
nanomolar affinity, and is coincidentally distributed in the 
Golgi apparatus with a previously described Golgi-associ- 
ated I3IE* spectrin (Beck et al., 1994). These findings sig- 
nificantly extend the known diversity of the ankyrins, con- 
firm the presence of a Golgi-associated 13IE* spectrin, and 
strongly imply that these two proteins function together as 
an integral part of the Golgi apparatus. We speculate that 
as with the plasma membrane, specialized variants of spec- 
trin and ankyrin organize microdomains within the ER, 
Golgi, and trans-Golgi networks, and may play a pivotal 
role in the process of targeted membrane assembly. 
Materials and Methods 
Isolation of Renal Ankyrin Clones 
All  molecular  biological  procedures  were  carried  out  using standard 
methods (Sambrook et al., 1989).  Oligonucleotides bracketing a  255-bp 
conserved region within the spectrin-binding domain of human erythro- 
cyte ankyrin were used in standard PCR reactions (Innis and Gelfand, 1990). 
The  sense  primer  was  5'-GCCCAGTGGGAAGACATAACAGG-3'; 
the  antisense  primer  was  5'-CTI~GTCCAC'ITrATCATCTGTCATG  - 
CAG-3'. Five templates were amplified: (a) human kidney eDNA library 
(Clontech Laboratories,  Palo  Alto,  CA);  (b)  rat  kidney eDNA library 
(Clontech); (c) rat kidney RNA reverse transcribed with random hexamer 
priming and avian myeloblastosis virus reverse transcriptase (Boehringer 
Mannheim Biochemicals, Indianapolis, IN); (d) MDCK cell RNA reverse 
transcribed as described above; and (e) LLC-PK1 cell RNA reverse tran- 
scribed as described above. Water was used as a  negative control for all 
PCR reactions. The absence of genomic DNA in the RNA samples was 
confirmed by the absence of amplified PCR products when no reverse 
transcriptase was used. PCR products were subcloned into the TA vector 
(Invitrogen, San Diego, CA),  and both strands were sequenced by the 
dideoxynucleotide chain termination method  (U.S.  Biochemical  Corp., 
Cleveland, OH). Subsequently, the random primer 3Zp-labeled PCR prod- 
uct was used to screen the human kidney eDNA library to isolate several 
overlapping clones. One rescreening of the library was required to obtain 
the 5' end and complete the AnkG119  cDNA sequence. 
Northern Blot Analysis of mRNA Expression 
Human multiple-tissue nylon membrane blots containing poly-A-selected 
mRNAs  (Clontech)  were  hybridized  to  a  random primer  3~P-labeled 
cDNA probe (the 255-bp PCR product) encoding human kidney ankyrin 
or a  control probe for actin and washed at high stringency. Hybridized 
bands were detected by autoradiography using X-OMAT film (Eastman 
Kodak Co., Rochester, NY) and fluorescent intensifying screens. 
Preparation of Antibodies to Ank~n9 
Antibodies to Ankc119 were produced from a  recombinant peptide. The 
255-bp PCR product from human kidney eDNA library was ligated in-frame 
to the expression vector pGEX-1N via the EcoR1 site. The pGEX vectors 
(Pharmacia Fine Chemicals, Piscataway, NJ) direct the bacterial synthesis 
of foreign  proteins  as  a  fusion peptide  with  glutathione S-transferase 
(GST) 1 (Smith and Johnson, 1988). Overnight cultures of transformed Es- 
cherichia coil were induced with 1 mM isopropy113-D-thiogalactoside  for 5 h 
at 37°C, pelleted, and resuspended in sonication buffer (containing 50 mM 
Tris-HCl, 50 mM NaCI, 1 mM EDTA, 1 mM PMSF, 10 p,g/ml leupeptin, 
10 p.g/ml aprotinin, 1 mM DTT, 1 mM benzamidine, pH 8). After over- 
night storage at -80°C, the suspension was thawed, brought to 1% (vol/ 
vol) Triton X-100, and sonicated at 70 W  for 15 s, repeated three times, 
with a sonic power apparatus (Branson Ultrasonics Corp., Danbury, CT). 
The lysate was centrifuged at 48,000 g for 20 rain, and the supernatant was 
affinity purified on a 2-ml glutathione-agarose column. The pelleted mate- 
rial was extracted by solubilization in 6 M  urea, 50 mM glycine, pH 9.0, 
and successively dialyzed in 2, 1, 0.5,  and 50 mM urea (each with 50 mM 
glycine, pH 9.0), and then affinity purified as described before. Extraction 
of the pellet yielded a 25-fold increase in the amount of fusion peptide ob- 
tained. The two fractions were pooled, rebound to a glutathione-agarose 
column, eluted with 50 mM Tris-HCl/5 mM reduced glutathione, pH 8.0, 
1. Abbreviation used in this paper: GST, glutathione S-transferase. 
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(at 40 mg/ml) was injected subcutaneously into New Zealand white rab- 
bits in complete Freund's adjuvant for antibody production (Morrow et 
al.,  1989).  Antibody  titers  of  hyperimmune sera  were  monitored  by 
ELISA assay using recombinant AnkoHg. 
Preparation of Cell and Tissue Lysates 
The outer renal cortices of Sprague-Dawley rats were harvested in 5 ml of 
PHEM buffer (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, 2 mM MgCl2, 
pH 6.9) containing 0.2% Triton X-100, 0.5 mM PMSF, 10 }xg/ml leupeptin, 
and 0.1  mM DTI" (Van Why et al., 1992).  After homogenization with a 
Potter-Elvehjem homogenizer and centrifugation at 35,000 g for 14 min at 
4°C, the pellets were resuspended in a volume of PHEM extraction buffer 
equal to that of the supernatants, and aliquots of each fraction were ana- 
lyzed by SDS-PAGE and Western blotting (Molitoris et al., 1992). 
MDCK cells grown to confluence in 150-cm  2 culture flasks in DME me- 
dium supplemented with 10% FBS and antibiotics were sequentially ex- 
tracted in situ as described before (Morrow et al., 1989; Devarajan ct al., 
1994).  Five extractions were performed: buffer 1 (yielding Fxl) contained 
10 mM Pipes, pH 6.8, 100 mM NaC1, 300 mM sucrose, 3 mM MgC12, 0.5% 
Triton X-100, 1.2 mM PMSF, 0.5 mM Pefabloc SC; buffer 2 (yielding Fx2) 
substituted 250 mM ammonium sulfate for NaC1, but was otherwise iden- 
tical to buffer 1; buffer 3 (yielding Fx3) was similar to buffer 1 but con- 
tained 50 mM NaCI, 100 ~g/ml of DNAse I, 100 lxg/ml RNAse, and 33 mg/ 
ml ammonium sulfate; buffer 4  (yielding Fx4) was 10 mM Tris-HCl, pH 
7.4, 9.5 M urea; buffer 5 (yielding Fx5) was 10 mM Tris-HCl, pH 7.4, 1% 
(vol/vol) 2-mercaptoethanol, 9.5  M  urea. Protein in the MDCK cell ex- 
tracts  was  assayed  by  Peterson's  modification  of  the  Lowry  method 
(Peterson, 1983).  Interfering buffer components were removed by precipi- 
tation of the protein with trichloroacetic acid in the presence of sodium 
desoxycholate (Bensadoun and Weinstein, 1976).  Analysis of these frac- 
tions by Western blots has shown that ~65%  of the immunodetectable 
spectrin is in Fx2, but a significant quantity (~30%) is also found in Fxl 
(data not shown), as has been previously reported for the 210-kD isoform 
of ankyrin in MDCK cells (Devarajan et al., 1994). 
Protease Digestions 
Human erythrocyte ghosts and MDCK cell lysate soluble (fxl) and cy- 
toskeletal  (fx2)  fractions  were  subjected  to  limited  tryptic  digestion 
(Weaver and Marchesi, 1984). Each sample at ~1 mg/ml total protein was 
exhaustively dialyzed against trypsin digestion buffer (5 mM NaHPO4, 20 
mM KCI,  1 mM EDTA, 0.5 mM 2-mercaptoethanol, pH 7.6)  and then 
treated with trypsin (L-l-tosylamido-2-phenylethyl chtoromethyl ketone- 
treated;  Worthington Biochemical Corp.,  Freehold,  N J)  at  an enzyme/ 
substrate ratio of 1:20 at 0°C for 30 min. Reactions were terminated by 
boiling with 4x  solubilizing buffer containing 12%  (wt/vol)  SDS, 5  M 
urea, 250 mM Tris-HCl, pH 7.5.  Aliquots were analyzed by SDS-PAGE 
and Western blotting with AnkR- and Ankol19-reactive antiserum. Alter- 
natively, the same substrates were subjected to digestion with }x-calpain 
(Harris et  al.,  1989)  after dialysis into calpain digestion buffer (20 mM 
Tris, 25 mM NaCl, 5 mM DTT, pH 7.5). Purified }L-calpain from porcine 
erythrocytes (Nacalai Tesque, Inc., Kyoto, Japan)  was diluted immedi- 
ately before use 1:10 into 50 mM Tris, 1 mM DTT, pH 7.5, and added to 
each sample at a  1:100  (vol/vol) ratio. Before the addition of ix-calpain, 
each sample was brought to 100 }xM in CaC12. Digestion was allowed to 
proceed for 20 rain at 30°C, and was terminated by boiling as described 
above. 
Expression of Recombinant Ankcu 9 Constructs 
Three sets of oligonucleotides were designed as shown in Fig. 8 a, so as to cre- 
ate three constructs spanning residues 457~592 (Ank W, 1595-2205 bp), 
669-860 (Ank J, 2135-2709 bp), and 850-1058 (Ank Y, 2680-3303 bp), all 
within the putative spectrin-binding domain of AnkGll9. Using the clone 
HKA R as template (Fig. 1), these constructs were amplified by standard 
PCR, subcloned, and sequenced to verify their identity. They were then li- 
gated in-frame into  the pGEX  vectors, expressed in bacteria  as fusion 
peptides with GST, and purified on a  glutathione-agarose column (De- 
varajan et al., 1994).  GST alone was also expressed as a control peptide. 
The four recombinant pepfides were eluted, dialyzed into spectrin-binding 
buffer (FBB; 50 mM Tris-HCl, pH 8.0, 50 mM NaC1,  1 mM DTT, 1 mM 
EDTA, 1 mM EGTA, 1 mM PMSF, 1 mM benzamidine, 1 mM Pefabloc 
SC), and aliquots were analyzed by SDS-PAGE and quantified by protein 
assay (Bio Rad Laboratories, Hercules, CA). Each fusion (50 }xg at 1 mg/ 
ml) was conjugated to 50 I~1 of a 50% slurry of glutathione-agarose beads 
for 1 h at 4°C with gentle rotation and used in binding assays. 
Binding Assays 
The interaction of AnkGll9 with spectrin in the soluble fraction (Fxl) of 
MDCK cell lysates was assayed in vitro by the ability of conjugated re- 
combinant AnkcH9 peptides to retain spectrin (Devarajan et al., 1994). 
Freshly prepared  Fxl  was dialyzed  into FBB  and preadsorbed  to  glu- 
tathione-agarose beads conjugated with GST alone for 4 h at 4°C. After 
pelleting at 13,000 g for 1 min, the supernate (~500 I~g total protein) was 
allowed to interact with each of the four fusion peptides (50 }xg each, pre- 
viously conjugated to GST and beads) at 4°C overnight with gentle rota- 
tion. The beads were pelleted and washed twice with FBB, and the aliquots 
were analyzed by SDS-PAGE. Bound spectrin was detected by Western 
blotting, with antibody directed against the 13IE* spectrin subunit. 
The interaction of Ankcn9 with  131 spectrin was measured quantita- 
tively using spectrin purified from fresh human erythrocytes (Morrow and 
Marchesi, 1981) and biotinylated by reaction of a 3 mg/ml solution in PBS 
with a 12-fold molar excess of sulfo-N-hydroxysuccinimide-biotin (Pierce 
Chemical Co., Rockford, IL) at 0°C for 2 h. Excess biotin was removed by 
exhaustive dialysis against PBS. Recombinant AnkGn9 peptide or control 
GST was incubated overnight in PBS with increasing amounts of labeled 
spectrin. Bound and free fractions were separated by absorption to glu- 
tathione-agarose as described before (Kennedy et al., 1994) and analyzed 
by SDS-PAGE. Free and bound spectrin were measured by an overlay as- 
say using HRP-avidin and enhanced chemiluminescence (Kennedy et al., 
1994). Each determination was compared to a series of standard protein loads 
using the same biotinylated spectrin and developed on the same transfer 
membrane. Binding results were analyzed by nonlinear regression after 
subtraction of the nonspecific binding to GST controls. All data was fitted 
as simple bimolecular binding, minimizing  the degrees of freedom of the fit. 
Immunofluorescence and Confocal Microscopy 
Cells were fixed and labeled in a modification of a previously used protocol 
for intact tissues (Van Why et al., 1992). Briefly, cells grown to confluence 
in Lab-Tek eight-chamber slides were fixed by exchanging the tissue culture 
media with one rapid wash of PBS followed by paraformaldehyde-lysine- 
periodate  fixative  (PLP)  for  a  minimum of  1  h  at  room  temperature 
(McLean and Nakane, 1974). Cells were then washed three times in PBS and 
used immediately for labeling, or they were stored in holding buffer (PBS 
0.2% formaldehyde) at 4°C for a maximum period of 10 d until labeling. On 
the day of labeling, the cells were gently permeabilized by freeze-thawing. 
In this procedure, the cells were treated with PBS, 10% DMSO for 15 min, 
and then rapidly frozen on an aluminum block at -35°C. They were then 
thawed by immersion in PBS, 1% BSA, 1% normal goat serum, and were 
allowed to remain in this solution to block nonspecific staining for 1 h at 
room temperature. Labeling of ankyrin antibodies was accomplished by ex- 
posing the cells to a titrated solution of preimmune and immune sera di- 
luted in PBS, 1% BSA, 0.1% normal goat serum for I h at room tempera- 
ture. Slides were gently agitated at 15-min intervals. The cells were then 
washed three times in PBS, and biotinylated anti-rabbit secondary anti- 
body (Vector Laboratories, Burlingame, CA) was applied at a 1:100 dilu- 
tion in PBS/BSA solution, as done with the primary antibodies. This was 
followed by an identical third step of exposing the cells to FITC-conju- 
gated avidin (Vector Laboratories) diluted 1:100 in PBS/BSA. Cells in ad- 
jacent chambers were labeled with a mAb for Na,K-ATPase using a two- 
step indirect labeling process involving exposure to the primary antibody, 
which was then followed after washing with rhodamine-conjugated goat 
anti-mouse antibody  (Cappel/Organon-Teknika, Durham,  NC)  1:200  in 
PBS/BSA. The slides were coverslipped in Vectashield (Vector Laborato- 
ries) to retard fading and were edge sealed with Cytosea160 (Stephens Sci- 
entific, Inc., Riverdale, N J) mounting media. Confocal microscopy was per- 
formed using a Bio Rad MRC-600 scanning laser microscope attached to a 
standard microscope (Carl Zeiss, Inc., Thornwood, NY) with a Leitz 50× 
water immersion lens (Leica, Inc., Deerfield, IL). Labeled cells and nega- 
tive controls were first visualized en face under identical microscope set- 
tings that were standardized with respect to illumination intensity, detec- 
tor amplifier settings, and confocal aperture size. Z  section microscopy was 
also performed on areas of interest to determine apical and basolateral do- 
main staining. In this procedure, the confocal aperture was set at its mini- 
mum section thickness, ~1.0 }xm with the objective lens used, and images 
were collected at 1.2-1~m steps so that no overlap between sections would 
be observed. Alternatively, conventional indirect fluorescent microscopy 
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NY) equipped for epillumination. 
Other Methods 
The isolation of total RNA from rat kidney, MDCK cells, and LLC-PK1 
ceils used standard methods (Chomczynski and Sacchi, 1987). SDS-PAGE 
and Western blotting  methods were as described  (Laemmli,  1970; Tow- 
bin  et  al.,  1979). Immunodetection of transferred  proteins  was  by  en- 
hanced  chemiluminescence  (Amersham Corp.,  Arlington Heights,  IL). 
Antibodies to a-Na,K-ATPase, AnkR, and  nonerythroid  speetrin  have 
been previously characterized (Morrow et al., 1989; Devarajan et al., 1994). 
The antibody to 13-COP was a kind gift from Dr. Ira Mellman (Yale Uni- 
versity, New Haven, CT) and has been previously described (Pepper- 
kok et al., 1993; Whitney et al., 1995). The mAb to 13I spectrin was mAb 
VIIIC7, which reacts with epitopes  near the center of 13I spectrin  (Harris 
et al., 1986). 
Results 
Cloning and Characterization of  a Novel Ankyrin  from 
Kidney Tissues (AnkG119  ) 
A  comparison  of published  eDNA  sequences  encoding 
human erythrocyte (Lambert et al., 1990; Lux et al., 1990a) 
and brain (Otto et al., 1991) ankyrins revealed a region of se- 
quence conservation in the spectrin-binding domain (be- 
tween residues 1183 and 1268 of human erythrocyte ankyrin). 
Oligonucleotides bracketing this highly conserved region 
amplified a 255-bp  product by PCR from five kidney tern- 
plates: a human kidney eDNA library, a rat kidney eDNA li- 
brary, reverse-transcribed MDCK cell RNA, reverse-tran- 
scribed LLC-PK1 cell RNA,  and reverse-transcribed  rat 
kidney RNA (Fig. 1 a). Nucleotide sequencing of several 
positive clones from each of the PCR reactions revealed 
that regardless of the templates that were used, just two 
families of sequences were detected (Fig. 1 b). One family 
included proteins that were highly homologous or identi- 
cal to human brain ankyrin, reinforcing immunologic data 
that AnkB is expressed in renal tissues (Otto et al., 1991). 
The other family of ankyrins (AnkG) included sequences 
that were  closely related  to  each  other  (>90%  identity 
over the 255-bp region amplified by PCR) but were dis- 
similar to any recognized ank~rins from brain or erythro- 
cytes. Comparing the human sequences over this region, 
AnkG119 displayed ~58 and ~64%  identity at the nucle- 
otide level (55-69%  identity at the amino acid level) to 
AnkR and AnkB, respectively (Fig. 1 c). Subsequent com- 
parisons to AnkG, which were not available when these 
studies  were  carried  out,  reveal  100%  identity  at  the 
amino acid and DNA levels over this region, confirming 
that it arises from the same gene as AnkG (ANK3). 
Using the 255-bp  PCR product as a probe, three over- 
lapping clones encoding a unique ankyrin sequence (HKA 
B, HKA S, and HKA R) were identified in the human kid- 
ney eDNA library (Fig. 1 d). Rescreening the library with 
HKA R yielded two additional overlapping clones (HKA Z 
Figure 1.  Cloning of AnkGll9. (a) Primers flank- 
ing  a  255-bp  conserved  region  in  the  spectrin- 
binding domains of previously described ankyrins 
were used to amplify a human kidney cDNA li- 
brary (lane 2), rat kidney cDNA library (lane 3), 
reverse-transcribed  rat  kidney  RNA  (lane  4), 
reverse-transcribed  MDCK  cell  RNA  (lane  5), 
reverse-transcribed LLC-PK1 cell RNA (lane 6), 
and water (lane 7, negative control). Lane 1 con- 
tains a HaeIII digest of +× 174 as a standard. The 
255-bp  PCR product  is indicated  by the  arrow. 
Ethidium bromide-stained  gel. (b)  The  derived 
amino  acid  sequences  of  the  clones  generated 
from the PCR amplified cDNA from each sam- 
ple fell into two related categories. Top, those re- 
lated  to  Anka;  bottom,  those  related  to  each 
other  but  distinct  from  Ank  B,  comprising  the 
new type of ankyrin called AnkGtjg. The origin of 
the numbered sequences correspond to the num- 
bered lanes in a.  CON, the consensus sequence. 
(c)  Comparison  of  the  derived  human  amino 
acid sequences of AnkR, AnkB, and Ank6119 over 
the  amplified  spectrin-binding  domain.  Con- 
served amino acids are indicated by dashes.  Hu- 
man  Anka  and  AnkGn9  share  66%  and  56% 
amino  acid  identity,  respectively,  to  human 
Ank  R over this region. (d) Overlapping AnkGl~9 
clones  obtained  by  screening  a  human  kidney 
cDNA library first with the AnkGll9 PCR prod- 
uct (HKA B, S, R) and then with HKA R (HKA 
Z,  X).  Comparison  of  the  full-length  deduced 
amino  acid  sequence  with  Ank  R and  AnkB  al- 
lowed the delineation of a 47-kD domain consist- 
ing of 13 ankyrin repeats, a 67-kD spectrin-binding 
domain,  and  a  very  truncated  5-kD  regulatory 
domain. 
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quence for AnkGH9 (GenBank No. U43965) with a putative 
polyadenylation signal (AATAAA)  17 bp upstream of the 
poly(A) ÷ tail  (Fig. 2).  The cDNA  sequence  has  a single 
open reading frame (with stop codons in all three reading 
frames upstream  of the  initiator methionine),  and it en- 
codes for a protein of 1,089 amino acids with a predicted 
molecular weight of 119,201  and isoelectric point of 8.2. 
Comparison  of  the  deduced  Ankou9  amino  acid  se- 
quence with previously described ankyrins  allows for the 
delineation of three putative ankyrin domains (Fig. 2). Af- 
ter a unique 5'-flanking sequence, AnkGH9 encodes just 13 
33-residue repetitive motifs characteristic of the ankyrins, 
in contrast to the 22-24  copies of this motif found in all 
previously  described  ankyrins.  As  a  result,  domain  I  of 
AnkGu 9 is 47 kD. The Ankol m repeats are identical to re- 
peats 12-24 of Anko and homologous to repeats 11-22 in 
AnkR and AnkB, indicating that Ankon9 is devoid of the 
first 10-11  repeats found in other ankyrins. The Ankou 9 
repeats domain is followed by a 67-kD putative spectrin- 
binding domain with strong homology to other  ankyrins 
and  a  remarkably  shortened  5-kD  regulatory  domain 
(starting with A-L-R as in AnkR) (Lux et al., 1990a), but is 
then followed by unique sequence. This divergent regula- 
tory domain cannot be an artifact of concatamer formation 
during library construction because it has been identified 
in two distinct clones  (Fig.  1),  and reverse  transcription 
PCR amplification of RNA derived from kidney tissue us- 
ing primers flanking the junction between the homologous 
ankyrin-like sequence and the novel 3' domain generated 
the  predicted  product  (data  not  shown).  Interestingly, 
these  primers  did  not  amplify  any  products  from brain 
RNA,  suggesting  that  this  3'  end  is  unique  to  Ankolt9. 
Overall, Anko119 is highly homologous to Ank~, and par- 
tially  homologous  to  AnkB  and  AnkR,  suggesting  that 
AnkoH 9 is a tissue-specific, alternatively spliced, and trun- 
cated isoform of Anko, but possesses unique 5' and 3' ends. 
While the similarities noted above clearly indicate that it 
GGAGC  TC  TTC  TCACTCAAGCCCGAGTTTC  TATGTTCAGACA.T2~TACATTCATCAC  TGTGTCCTTCCAGGATTTGGAAGTCTGACAAAACACC  ATTC  CAGJ~.~C  T  tO5 
~,R1 
GCATC  TCCAGGTTTTGA6  TCTAGAAATGAATTTAAGATGTGATC  TCTTGGATAAGAAAGC  TAACCCCAATGCCAAAGCCCTGAATGGCTTTACCCCTCTTCATAT 210 
M  N  L  R  C  O  L  L  9  K  K  A  ~  P  ~  A  K  A  l  N  G  F  T  P  L  H  I  27 
~,  R2 
TGCC TGCAAGAAGAATCGAATTAAAGTAATGGAACTCCTTCTGAAACACGGTGCATCCATCCAAGC  TGTAACCGAGTCGGGCC TTACCCCAATCCATGTTGC TGC  318 
A  C  K  K  N  R  I  K  V  M  E  L  L  L  K  H  G  A  $  I  0  A  V  T  E  S  G  L  T  P  I  H  V  A  A  82 
~,  R3 
C  T  TCATGGG•CATGTAAATATTGTATCACAACTAATGCATCATGGAGCCTCACCAAACA•CACCAATGTGAGAGGAGAAACAGCACT•CACATGGCA•C  TCGCTC  q20 
F  M  G  H  V  N  ]  V  $  Q  L  M  H  H  G  A  S  P  N  T  T  N  V  R  G  E  T  A  L  H  M  A  A  R  S  97 
CGGC CAAGC  TGAAG  TTG TGCGGTATC TGGTACAAGACGGAGCTCAGGTAGAAGC TAAAGC  TAAGGATGACCAAACACCACTCCACATTTCAGCCCGACTGGGGAA  526 
G  0  A  E  V  V  R  Y  L  V  Q  D  G  A  Q  V  E  A  K  A  K  D  D  Q  T  P  L  H  ]  S  A  R  L  G  K  132 
~,  RB 
AGCAGACATAG  TACAACAGCTG  TTGC AGCAAGGGGC  AT¢ TCCAAATGCAGCCACAACTTC TGGGTACACCCCACTTCACCTTTCCGCECGAGAGGGGCATGAGGA  830 
A  D  I  V  Q  Q  L  L  Q  Q  G  A  S  P  N  A  A  T  T  S  G  Y  T  P  L  H  L  $  A  R  E  G  H  E  D  187 
~,  RB 
TG TGGCCGCGTTCC TT TTGGATC AIGGAGCG  TCTTTATC TATAACAACAAAGAAAGGATTTACTCC  TC TTCATGTGGCAGCAAAA TA  TGGAAAGC  TTGAAGTCGC  736 
V  A  A  F  L  L  D  H  G  A  S  L  S  I  T  T  K  K  G  F  T  P  L  H  V  A  A  K  Y  G  K  L  E  V  A  202 
~,  R7 
CAATCTCC TGC TACAGAAAAG  TGCATCTCC AGATGC  TGCTGGGAAGAGCGGGCTAACACCAC TGCATGTAGC TGCACATTACGATAATCAGAAAGTGGCCCTTCT  8~0 
N  L  L  L  Q  ~-  S  A  S  P  D  A  A  G  K  S  6  L  T  P  L  H  V  A  A  H  Y  D  N  Q  K  V  A  L  L  237 
~.  R8 
GC TTT TGGACC AAGGAGCC  TC AC  C  TCACGCAGCCGCAAAG  AATGG  TTATACGCC ACTGCACATCGC TGCCAAAAAGAACCAGATGGACATAGCGACAACTC  TGCT  9q5 
L  L  D  Q  G  A  S  P  H  A  A  A  K  N  G  Y  T  P  L  H  I  A  A  K  K  N  0  M  D  I  A  T  T  L  L  272 
4"  R9 
GGAATATGG TGCTGATGCCAACGC AG  TTAC  CCGGCAAGGAATTGCTTCCGTCC  ATC TCGCAGCTC AGGAAGGGCACGTGGACATGGTGTCGC  TGCTCC TCGGTA6  1050 
E  Y  G  A  D  A  N  A  V  T  R  Q  G  I  A  S  V  H  L  A  A  Q  E  G  H  V  D  M  V  S  L  L  L  G  R  307 
AAATGCGAATGTGAACC TGAGCAATAAGAGCGGCCTGACC CCACTCCATTTGGCTGCTCAAGAAGATCGAGTGAATGTGGC  AGAAGTCC  TCGTAAACCAAGGGGC  1188 
N  A  N  V  N  L  S  N  K  S  G  L  •  P  L  H  L  A  A  Q  E  D  R  V  N  V  A  E  V  L  V  N  0  G  A  3~2 
RII 
TCATGTGGACGCCCAGACAAAGATGGGATACACACCACTGCATGTGGGCTGCCAC  TATGGAAATATCAAGATTGTTAATTTCCTGCTCCAGCATTCTGCAAAA6T  ~280 
H  V  D  A  0  "i  K  M  G  Y  T  P  L  H  V  G  C  H  Y  G  N  I  K  I  V  N  F  L  L  O  H  S  A  K  V  377 
,~  R12 
TAATGCCAAAACAAAGAATGGGTATACGCC  ATTACATCAAGCAGCAC  AGCAGGGGCATACGCATATAATAAATG TCTTACTTCAGAACAACGCCTCCCCCAATGA  1368 
N  h  K  T  K  N  G  Y  T  P  L  H  0  A  A  Q  Q  G  H  T  H  I  I  N  V  L  L  0  N  N  A  S  P  N  E  q12 
~.  R13 
AC  TC  AC  TG  TGAATGGGAATAC  TGCCCTTGGCATTGCCCGGCGGC  TCGGCTACATC  TCAGTAGTGGACACCC  TGAAGATAGTGACCGAAGAAACCATGACCACAAC I~70 
L  T  V  N  G  N  T  A  L  G  [  A  R  R  L  G  Y  I  $  V  V  D  T  L  K  I  V  T  E  E  T  M  T  T  T  qq7 
•  spectrJt~  Dindlng  domosn  ~torts 
TAC  TGTC  ACAGAGAAGC  ACAAAATGAATG  TTCCAGAAACGATGAATGAAGTTCT  TGATATGTC  TGATGATGAAGGTGAAGATGC  AATGACCGGGGACACAGACAA 1575 
•  v  T  E  K  H  K  M  N  V  P  E  T  M  N  E  V  L  0  M  S  0  0  E  G  E  D.  ,~  M  T  G  D  T  D  K  q82 
ATATC  TTGGGCCACAGGACCTTAAGGAATTGGGTGATGATTCCCTGCC  TGCAGAGBGTTACATGGGCTTTAGTC  TCGGAGCGCGTTC TGCC  AGCGATAGGTCTTA  1880 
Y  L  G  P  '3  {]  L  K  E  L  G  O  D  S  L  P  A  E  G  Y  M  G  F  S  L  G  A  R  S  A  S  0  R  S  Y  8~7 
CACC  TTGAACAGAAGC  TCC TATGCACGGGACAGCATGATGATTGAAGAAC TCCTTGTGCC ATCCAAAGAGCAGCATC  TAACATTCAC  A,,'  GGGAATTTGATTCAGA  17(~5 
T  L  N  R  S  S  Y  A  R  D  $  H  M  [  E  E  L  L  V  P  S  K  E  Q  H  L  T  F  T  R  E  F  D  S  D  552 
TTCT•TTA•A•ATTACAG•TGGGC•GCAGA•A••TTAGACAATGT•AAT•TTGTTTCAAGC•CCATT•ATT•TG•GTTT•TGGTTA••TTTA••GTG•AC•C•A•  1890 
SLRHYSWAADTLDNVNLVSSPIHSGFLVSFMVDAR887 
AG•G•G••CCATGAGAGGAAGCCGT•AT•A•GGGATGAGAAT•ATCATTC•TCCACGCAAGTGTACG••CCCCACTCGAAT•ACCT•CCGTTTG•TAAAGAGACA  19g8 
GGSMRGSRHHGMRII[PPRKCTAPTRITCRLVKRH822 
TAAACTGGCCAA~CACCC~ACATGGTGAAAGGAGAGGGATTAGCAGTA~GCTGGTAGAAATGGGT~CTGCAGG~G~ACAATTTTTAGGC~CTGT~A~T~GA  2100 
KLANPPPHGERRG]SSRLVE'MGPAGAQFLGPVIVE657 
AATCC~CACTTTGGGTCCA~GAGAGGAAAAGAGAGAGAACTCA~TGTTCTTCGAAGTGAAAATGGTGAAAC~TGGAAG~AGCATCAGTTTGACAGCAAAAATGA  2205 
IPHFGSMRGKEREL]VLRSENGETVKEHQFDSKNE692 
AGATTTAACCGAGTTACTTAATGGCATGGATGAAGAACTTGATAGCCCAGAAGA•TTAGG•AAAAAGCGTATCTGCAG•ATTATCACGAAAGATTTCCCCCAGTA  2310 
DLTELLNGMDEELDSPEELGKKRICRIITKDFPQY727 
TTTTGCAGTGGTTTCCCGGATTAAGCAGGAAAGCAACCAGATTGGTCCTGAAGGTGGAATTCT•AGCAGCACCACAGTGC•CCTTGTTCAAGCAT•TTTCCCAGA  2q18 
FAVVSRIKOESNQIGPEGGILSSTTVPLVQASFPE762 
GGGTGCCCTAACTAAAAGAATTCGAGTGGGCCTCCAGGCCCAGCCTGTTCCAGATGAAATTGTGAAAAAGATCCTTGGAAACAAAGCAACTTTTAGCCCAATT•T  2820 
GALTKRIRVGLQAQPVPDEIVKKILGNKATFSPIV797 
CACTGTGGAACCAAGAAGACGGAAATTCCATAAACCAATCACAATGACCATTCCGGT•CCCCCGCC•TCAGGAGAAGGTGTATCCAATGGATACAAAGGG•A•AC  2625 
TVEPRRRKFHKP[TMTIPVPPPSGEGVSNGYKGDT832 
TACACCCAATCTGCGTCTTCTCTGTAGCATTACAGGGGGCACTTCGCCTGCTCA•TGGGAAGACATCACA•GAACAACTCCTTTGACGTTTATAAAAGATTGTGT  2730 
TPNLRLLCSITGGTSPAQWEDITGTTPLTFIKDCV867 
CTCCTTTACAACCAATGTTTCAGCCAGATTTTGG£TTGCAGACTGCCATCAAGTTTTAGAAACTGTGG•GTTA•CCACGcAACT•TACA•AGAATTGATATGTGT  2835 
SFTTNVSARFWLADCHQVLETVGLATQLYRELICV  ~2 
TCCATATATGGCCAAGTTTGTTGTTTTTGCCAAAATGAATGATCCCGTAGAATCTTCCTTGCGATGTTTCTGCATGACAGATGACAAAGTGGACAAAACTTTAGA  2gqo 
PYMAKFVVFAKMNOPVESSL~CFCHTDDKVDKTLE937 
GCAACAAGAGAATTTTGAGGAAGTCGCAAGAAGCAAAGATATTGAGGTTCTGGAAGGAAAACCTATTTATGTTGATT•TTATGGAAATTT•GCCC•ACTTACCAA  ~q5 
OQENFEEVARSKDIEVLEGKPIYVDCYGNLAPLTK972 
AG~AGGACAGCAACTT~TTTTTAACTTTTATTCTTTCAAAGAAAATAGACT~CCATT~TCCATCAAGATTAGAGACACCAGCCAAGAGCCCTGTG~TCGTCTGTC  3180 
GGOOLVFNFYSFKENRLPF$1KIRDT$QEPCGRLSI~7 
TTTTCTGAAAGAACCAAAGACAA•AAAAGGACTGCCTCAAACAGCG•TTTGCAACTTAAATATCACTCTGCCA•CACATAAAAAGATTGAGAAAACAGATAGACG  3285 
FLKEPKTTKGLPQTAVCNLNITLPAHKKIEKTDRRIOQ2 
•  regulutory  domo~n stort~ 
ACAGAGCTTCGCATCCTTAGCTTTACGTAAGCGCTACAGCTACTTGACTGAGC~TGGAAT~A~TGAGTTTCCTGACACGTCCACTAATCCG~GTCAATG~TTTAG  3360 
QSFASLALRKRYSVLTEPGMSEFPOTSTNPGQCFRI077 
GAGAAGAGACATTT~TTCTATGCGCTCTAAATTATGATGTGGTTTCGAAAA~AACGCCCTGGGCCAAAAAAAAAAAAAAAAAAAAAAAAAAAA  348q 
RRDIFSMRSKL.  108~ 
Figure 2.  Nucleotide sequence, deduced  amino 
acid sequence, and putative domain structure  of 
human kidney Ankong. The beginning of each 
repeat is marked. The stop codons in all three 
reading  frames  upstream  of  the  initiator  me- 
thionine are  underlined. The putative polyade- 
nylation site  is  in bold  and  underlined. (Gen- 
Bank accession No. U43965). 
Devarajan et al. Golgi-associated Ankyrin  823 Figure 3.  ANKGt19  is expressed in a restricted  subset of human 
tissues.  A  Northern  blot  containing  poly-A-selected mRNAs 
from human tissues was hybridized  to a human ANKGH9  probe. 
Transcript  sizes  in  kilobases  are  indicated  on  the  left;  tissue 
sources are as indicated. Note the presence of a prominent 6.0-kb 
band in the kidney, placenta, and skeletal muscle. The larger bands 
seen in the brain and some other tissues reflect cross-hybridization 
with other transcripts  of Ank6 (Kordeli et al., 1995). Hybridiza- 
tion of this blot with a human ~/-actin probe revealed equal load- 
ing of all lanes (not shown). 
arises  from  the  same  gene,  AnkGll9  differs  from  brain 
AnkG in several respects. Pairwise sequence alignment of 
AnkGt19 vs brain AnkG using either Bestfit (University of 
Wisconsin  Genetics Computer Group)  (Devereux et al., 
1984)  or MegAlign  (DNASTAR, Inc., Madison,  WI) re- 
veals five specific regions of deleted or altered sequence. 
The first six residues of Ankc119 are unique, as are the first 
385  residues of brain AnkG. Compared to Ank  G, AnkGn9 
deletes  (a)  18  residues  between  positions  850-869  of 
Ankc; (b) 6 residues between positions 912-919 of AnkG; 
and (c) 9 residues between Ank6 positions 1,441-1,451. In 
addition,  after residue  1477  of AnkG, AnkG119 displays a 
unique 27-residue (amino acids 1063-1089) COOH termi- 
nus vs the  901  residue  (amino acids  1477-4378)  COOH- 
terminal domain of Ank~. 
AnkG119 Is Expressed Primarily in Kidney, Placenta, 
and Skeletal Muscle 
Northern blot analysis of AnkG119 mRNA expression using 
the 255-bp PCR product as a probe revealed a major 6.0-kb 
transcript in the human kidney, placenta, and skeletal mus- 
cle, and in rat kidney tissue.  Upon longer exposures, the 
AnkGt19 cDNA probe also hybridized with a 7-kb message in 
kidney tissue, 9- and 14-kb species in the brain, 8- and 9-kb 
messages in the heart, and faint 7--8-kb messages in intesti- 
nal tissues and ovary (Fig. 3). No message was detected in 
leukocytes or in the liver. Presumably, these bands repre- 
sent either cross-hybridization with other ankyrins (given 
the strong sequence conservation between different ankyrins 
over some part of their structure), or more likely, other al- 
ternatively spliced products of the AnkG gene (Kordeli et 
al., 1995; Peters et al., 1995). Hybridization of these blots 
after stripping of the AnkG~19 cDNA probe with a human 
"v-actin  cDNA probe revealed equal loading of the actin 
message in all lanes. 
Antibodies to AnkGu9 Recognize a ll6-kD Peptide in 
the Soluble Pools of Renal Cell Lysates 
A recombinant peptide representing the 255-bp PCR prod- 
uct of AnkG119 (Fig.  1,  clone HKA P) was prepared and 
Figure 4.  Antibodies to AnkGt19 identify a 116-kD protein in kid- 
ney and muscle lysates. (a) Polyclonal antibodies raised to a 37-kD 
recombinant human GST-Ank6n9 fusion  peptide or antibodies 
raised  to AnkR were used to identify  immunoreactive bands in 
various tissues. Lane 1, GST-AnkG119 peptide alone; lane 2, hu- 
man erythrocyte ghosts;  lane  3,  bovine brain  (cortex);  lane  4, 
MDCK cells; lane 5,  mouse C2C12 (muscle)  cells. Left panel, 
Coomassie blue stain; center  panel, anti-AnkR Western blot; right 
panel, anti-Anko~19  Western blot. (b) Distribution  of AnkG119 and 
Ankg in rat renal cortical tysates. The Triton-soluble (s) and -in- 
soluble pellet (p) fractions  of rat renal cortical lysates were ana- 
lyzed  for the presence of AnkGn9 (left panel) or  Ank  R (right 
panel) by Western blot. Note that AnkG~19  distributed to the solu- 
ble fraction, while Anka reacted with an ,~190-kD peptide in the 
pellet fraction.  (c) Distribution  of Ank6119 and AnkR in MDCK 
cell lysates. Western analysis as described  above was carried  out 
on sequentially  extracted MDCK cell lysates (see Materials  and 
Methods).  The fraction numbers are given. Note that all immu- 
noreactive Ankc119 was in the soluble fraction (Fxl, lane 1) (top 
panel), while Anka (~215 kD in these canine cells) was predomi- 
nantly  in the  cytoskeletal  fraction  (Fx2,  lane 2),  as previously 
noted (Devarajan et al., 1994). 
purified  as a  fusion protein with  GST. This peptide  was 
used  to  generate  a  polyclonal  antibody  that  specifically 
recognized this fusion protein on Western blots (Fig. 4 a). 
This antibody did not react with any proteins in erythro- 
cyte ghosts or in the bovine brain. A  protein with an ap- 
parent molecular mass of 116 kD was detected in MDCK 
cells and in C2C12 cells, a myoblast cell line. By compari- 
son, an antibody to AnkR detected immunoreactive bands 
between 190 and 220 kD in all cell samples, representing 
previously described  ankyrin species. These observations 
were refined by examining the solubility properties of the 
peptide being detected by anti-AnkGx19. Unlike the 190-kD 
ankyrin recognized by AnkR antibodies, the ll6-kD AnkG119 
The Journal of Cell Biology, Volume 133, 1996  824 was present only in the Triton-soluble fraction of rat kid- 
ney cortical tissue (Fig. 4 b). 
A  similar segregation of the ll6-kD peptide into a solu- 
ble pool was also apparent in cultured confluent MDCK 
cells. Under conditions of sequential extraction of various 
cellular elements, we  have previously demonstrated  that 
the 210-kD immunological counterpart of AnkR in MDCK 
cells is found predominantly in the "cytoskeletal" fraction 
(Fx2) (Devarajan et al., 1994).  Under identical extraction 
conditions, the ll6-kD AnkG119 is found exclusively in the 
soluble pool (Fig. 4 c). 
Ankat19 Codistributes with Golgi Markers 
and fllZ* Spectrin 
Immunofluorescence  confocal  microscopy with  antibod- 
ies to AnkGll9 produced a largely diffuse but punctuate cy- 
toplasmic staining in stable and  highly confluent MDCK 
cells (Fig. 5, c and f), as well as in LLC-PK1 cells and intact 
renal tubule cells (data not shown). In contrast, antibodies 
directed  against  ANKR  demonstrated  a  basolateral  and 
somewhat apical membrane distribution  (Fig. 5, b  and e), 
while  the  distribution  of the  et subunit  of Na,K-ATPase 
(Fig. 5, a  and d) was basolateral, as expected in these ma- 
ture  MDCK  cells.  The  etII[3II spectrin  (fodrin)  in  these 
cells was also predominantly localized to the  basolateral 
membrane (data not shown) (Nelson and Veshnock, 1986; 
Koob et al., 1988; Morrow et al., 1989). 
When isolated or subconfluent MDCK cells were exam- 
ined,  a  different intracellular  distribution  became appar- 
ent  (Figs. 6  and 7).  Under these conditions, in which full 
epithelial  cell  polarity had  not  yet been  established,  in- 
tense anti-AnkG119 staining was concentrated eccentrically 
near the nucleus, with less punctuate cytoplasmic staining 
apparent  (Figs.  6,  a  and  d,  and  7  a).  This  pattern  was 
strongly suggestive of Golgi staining and was confirmed as 
such by its coincidence with the staining pattern of [3-COP 
(Fig. 6, e and g).  [3-COP is the best-characterized compo- 
nent of the  cytoplasmic coatamer proteins that  assemble 
on COP I vesicles involved in the transport of newly syn- 
thesized  proteins  between  the  ER,  the  Golgi,  and  the 
trans-Golgi network  (Pepperkok et al.,  1993;  Griffiths et 
al.,  1995).  Recent data has also implicated [3-COP in the 
function  of  some  types  of  endosomes  (Whitney  et  al., 
1995).  AnkGH9 was  also  found  to  be  colocalized  in  the 
Golgi with 13I~* spectrin, as revealed by its coincident im- 
munostaining with mAb VIIIC7 (Figs. 6, b and h, and 7 b). 
The 116-kD AnkGu 9 Is Not a Proteolytic Fragment of a 
Conventional Ankyrin 
The size of the AnkGl19-immunoreactive peptide, as well 
as its cytoplasmic and  Golgi distribution,  are novel for a 
member of the  ankyrin  superfamily.  Previous  work  has 
demonstrated that proteolysis of ankyrin from either brain 
or red cells yields fragments in the size range of 40-120 kD, 
and that many of these fragments lack the putative mem- 
brane-binding domain (Davis and Bennett,  1984; Weaver 
et al., 1984). Therefore, the reactivity of the anti-AnkG119 
antibody with proteolytic fragments of conventional renal 
ankyrins was of concern.  To exclude  the  possibility that 
the anti-AnkG119  was recognizing only a  new epitope cre- 
ated by the proteolysis of a conventional ankyrin, extracts 
Figure 5.  The distribution  of Ank6119 is cytoplasmic and distinct 
from that of AnkR by indirect  immunofluorescent microscopy. 
Cultured MDCK cells were fixed and immunostained after sev- 
eral days at confluence to determine the distribution  of (a and d) 
a-Na,K-ATPase, (b and e) AnkR, and (c and f) Ank6119. Note the 
punctate  cytoplasmic  distribution  of Ank6119 compared to  the 
plasma  membrane  compartmentalization  of  both  Anka  and 
Na,K-ATPase. In such confluent  and stably polarized cells, the 
association of AnkGn9 with Golgi membranes is largely inappar- 
ent (compare with Fig. 6). The z-axis micrographs in d-f were 
constructed  from a series of z-axis line scans recorded at 1.2-1xm 
levels using the standard BioRad 600 confocal  microscope soft- 
ware. Bar, 10 ixm. 
of MDCK cells were subjected to proteolysis with either 
p~-calpain  or  trypsin,  and  the  resulting  breakdown  prod- 
ucts  were  examined by Western  blotting with  either  the 
AnkGll9 or AnkR antibodies. Erythrocyte ghosts were also 
Devarajan et al. Golgi-associatedAnk3,rin  825 Figure 6.  in subconfluent MDCK cells, AnkG~19 and J3I~2  * spectrin codistribute with B-COP, a Golgi marker. Cultured MDCK cells were 
sparsely plated, fixed, and immunostained before achieving confluence. The distribution of Ankc5119 (a and d), [3IE* spectrin (b and h), 
or B-COP (e and g) were determined by indirect immunofluorescence. Each row represents double-immunostained preparations. The 
rightmost column (c, f, and i) represents the appearance of the preparation in each row when viewed through a  filter that passes the 
emission of both CY-2 (green) and CY-3 (red). Areas of absolute coincidence are revealed as yellow. Note the strong coincident staining 
over the Golgi complex. As seen in fully confluent MDCK cells, there is no staining at the plasma membrane. Bar, 50 vtm. 
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trin  are  closely  codistributed  in 
subconfluent MDCK cells. Sparsely 
plated MDCK cells were stained 
for  either  ~I~*  spectrin  (mAb 
VIIIC7) (a) or AnkGn9 (b), as de- 
scribed in Fig. 6. Their overlapping 
distributions  are depicted  by the 
yellow signal in c. Note that with 
few exceptions,  the two proteins 
are highly coincident. Bar, 10 ~m. 
examined in these assays.  Both the conventional 210-kD 
renal ankyrin (recognized by anti-AnkR in the cytoskele- 
tal fraction, Fx2) and the ll6-kD AnkG119 (in the soluble 
fraction, Fxl) were degraded by these proteases (Fig. 8). 
The AnkG119 antibody reacted with a breakdown product 
at ~20 kD in the soluble fraction after trypsin treatment. 
No  breakdown  products  were  detected  after  ~-calpain 
treatment.  The  AnkR  antibody  recognized  an  array  of 
breakdown products after p~-calpain and trypsin treatment 
in erythrocyte membranes and in the cytoskeletal fraction 
of MDCK cells, although the fragmentation patterns were 
not identical (Fig. 8). Importantly, no 116-kD peptide that 
would react with the AnkG119 antibody was generated at 
any point in the proteolysis of the cytoskeletal fraction of 
MDCK cells or of red cell ghosts. The pattern of fragments 
generated from the proteolysis of AnkG~9 was also not a 
subset of the fragments generated by similar conditions 
of  proteolysis  of  the  AnkR,  based  on  their  molecular 
weights. These distinct patterns of proteolytic breakdown 
and immunoreactivity between renal AnkG119 and  AnkR 
indicate that the 116-kD Ankol19-immunoreactive protein 
observed in the cytoplasmic pool cannot be merely a pro- 
teolytic fragment of a conventional, membrane-associated 
renal ankyrin. 
AnkG119 Binds to MDCK Cell [3I- and [3II-Spectrin 
In Vitro 
Since  AnkG119 was  identified  based  on  homologies  in 
ankyrin's spectrin-binding domain, it was of interest to de- 
termine if the 116-kD AnkGv9 retained bonafide spectrin- 
binding activity. The putative spectrin-binding domain of 
Anko119 was  expressed in  bacteria  as  three overlapping 
GST fusion peptides (Fig. 9 a), purified over a bioaffinity 
column, and assayed for its ability to retain spectrin from 
fxl (soluble) of MDCK cell lysates. Each of the recombi- 
nant peptides was soluble, stable, and of the predicted mo- 
lecular weight  by SDS-PAGE  analysis  (Fig.  9  b).  Only 
peptide pGEX-HKA J specifically and reproducibly bound 
both 13II-spectrin  (Fig. 9 b) and ~I-spectrin (Fig. 9 c). This 
peptide  represents  residues  669-860  of AnkGt19 (Fig.  9, 
shaded area), a region highly conserved between all known 
ankyrin isoforms (100% homology with AnkG, 80% with 
AnkB,  and  67%  with  AnkR).  Interestingly, the  spectrin- 
binding  domain  previously  identified  in  residues  1136- 
1160 of AnkR (Platt et al.,  1993) is highly homologous to 
AnkGn9 residues 801-825  contained within the spectrin- 
binding recombinant peptide pGEX-HKA J. 
Given the coincident localization of AnkGH9 with 13IE* 
spectrin in MDCK cells (Fig. 8), the strength of the inter- 
action between these proteins was of interest. The I3IE* 
spectrin  in  kidney cells remains  incompletely character- 
ized  although  it  is  immunologically most  similar  to  the 
[3I~1 spectrin from erythrocytes (Beck et al., 1994), a point 
further confirmed by its reactivity with mAb VIIIC7  re- 
ported here. Therefore, the ability of the AnkGn9 spectrin- 
binding domain to associate with 13IE1 spectrin from red 
cells was measured (Fig. 10). These two proteins interacted 
strongly, with an apparent Kd =  4.2 _  4.0 (+_2 SD) nM. 
Figure 8.  The protease digestion pattern of Ankoll9 is distinct 
from AnkR. Erythrocyte ghosts (left panel)  or the MDCK cells 
extracts fxl (right panel) or fx2 (center panel) were partially di- 
gested with either ~-calpain  or trypsin. Lanes 1 and 3, starting 
material; lane 2, trypsin digest; lane 4, ~-calpain digest. Each di- 
gest was immunoblotted  with either anti-Ankola9 or anti-AnkR 
antibodies, as indicated. Note that a ll6-kD peptide that is immu- 
noreactive with AnkGl~9 antibodies is not generated by proteoly- 
sis from any extract,  and that the protease digestion pattern of 
AnkGl~9 is distinct from that of AnkR. 
Discussion 
These studies identify a  novel truncated spectrin-binding 
ankyrin, AnkG119  , in kidney and muscle tissue that is asso- 
ciated with the Golgi apparatus.  This molecule has many 
unusual features. Specifically: (a) cDNA cloning of AnkG119 
reveals  strong  sequence  homology within  the  spectrin- 
binding domain of conventional ankyrins; (b) the putative 
regulatory domain of conventional ankyrins is  markedly 
truncated in AnkGll9  , and what sequence exists in this do- 
main is unique and unrelated to any other known ankyrin; 
(c) a large part of the 33-residue ankyrin repeat structure 
characteristic  of  this  family  of  proteins  is  absent;  (d) 
AnkG119 expression is largely restricted to or at least most 
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AnkG119 with biotinylated cdl~I spectrin was measured quantita- 
tively by incubating increasing amounts of biotinylated erythro- 
cyte spectrin with a fixed amount of the pGEX2T-AnkJ construct 
or GST alone, after which the AnkJ peptide with any bound spec- 
trin was separated by absorption to glutathione-Sepharose, ana- 
lyzed by SDS-PAGE, and the amount of bound spectrin was de- 
termined  (in  arbitrary units)  by overlay with  HRP-avidin. The 
extent of binding is expressed as a fraction of the maximal binding 
(Bmax) estimated by nonlinear regression analysis of the binding 
isotherm. The fitted curve yielded an estimated Kj  =  4.8  +-- 4.0 
nM (+-2 SD). (Inset) Western blots of the supernatant (S) or pel- 
let fractions (P) from one of the experiments demonstrating the 
specific binding of spectrin to the AnkG119 construct. 
Figure 9.  AnkG119  binds to MDCK cell spectrin in vitro. (a) The 
putative  spectrin-binding  domain  of AnkG119  was expressed  as 
three overlapping GST fusion peptides (pGEX2T-Ank W at 54 kD; 
pGEX2T-Ank J  at 48.5  kD;  pGEX1N-Ank  Y  at 50  kD).  The 
basepair positions of each construct with respect to the full-length 
clone (Fig. 2) is depicted. The relationship of these constructs to 
the full-length Ank~119 amino acid sequence is depicted in the bar 
at the top of the figure with the residue numbers indicated. The 
shaded area represents the minimal spectrin-binding domain that 
is identified  in these  studies.  (b)  Top, Coomassie blue-stained 
SDS-PAGE  gel  showing,  respectively, from  left  to  right  GST 
alone at 27.5 kD, the Ank W, Ank J, and Ank Y fusion peptides, 
and the soluble fraction (fxl) from MDCK cell lysates. Bottom, 
Western blot of the lysate retained by each fusion peptide and of 
Fxl alone, using an antibody directed against 131I spectrin. Note 
that  only  the  AnkJ  construct  interacted  with  13II spectrin  in 
MDCK cell fx 1. (c) Western blot of the same lysate as in b that 
was retained by each fusion peptide and of Fxl alone, now using 
mAb  VIIIC7  antibody  directed  against  13IE* spectrin.  Again, 
note that the AnkJ peptide also interacts with this form of 13 spec- 
trin from the MDCK cell fxl. 
abundant  in the kidney, placenta,  and skeletal muscle; (e) 
AnkG119 binds spectrin with high affinity; Q') AnkG119 does 
not associate with the plasma membrane; (g) AnkG119  and 
13IE* spectrin are colocalized with 13-COP in incompletely 
polarized (subconfluent)  MDCK cells; and (h) AnkG119 is a 
substrate  in  vitro  for  trypsin  but  resists  ~-calpain  diges- 
tion.  Collectively,  these  studies  substantively  expand  our 
understanding  of the  ankyrin  gene superfamily,  and  they 
suggest that members of this family of proteins, together with 
other components of the spectrin-actin skeleton, may play 
a  role in intracellular  vesicle trafficking or other processes 
that transcend plasma membrane "anchoring" functions. 
The  possible  relationship  of AnkG119  to the  only  other 
known  "small ankyrin,"  the  72-kD  ankyrin-like  molecule 
previously  described  in  T  lymphocytes  (Bourguignon  et 
al., 1986), is provocative. In that study, a molecule with im- 
munologic  and  peptide  map  similarities  to  ankyrin  was 
found  to  bind  both  spectrin  and  the  membrane  protein 
GP85.  It is unlikely  that this molecule was AnkG119,  since 
AnkGa19 is larger in size, is not found in lymphocytes, and 
is  not  associated  with  the  plasma  membrane.  However, 
other alternative transcripts of AnkG appear to exist (Kor- 
deli et al., 1995; Peters et al., 1995), and in several other re- 
spects,  the  lymphocyte 72-kD  ankyrin  appears  similar  to 
AnkGv9. While  sequence  or cloning  data on the  lympho- 
cyte  ankyrin  is  lacking,  certain  conclusions  can  be  sur- 
mised.  Both  molecules  are  smaller  than  conventional 
ankyrins.  Both  bind  spectrin,  and  thus  must  presumably 
conserve  the  central  spectrin-binding  domain  of ankyrin. 
Both  lack  part  or all  of the  repetitive  33-residue  domain 
that is characteristic of the conventional  ankyrins. This re- 
gion is responsible  for membrane  binding,  and  its partial 
absence in AnkGa19  may explain the solubility of AnkG119. 
We postulate  that the  defining characteristic  of these  un- 
conventional ankyrins will be their spectrin-binding capac- 
ity, and  that linked  to the  spectrin-binding  motif by exon 
splicing  or  other  mechanisms  will  be  additional  protein 
cassettes  bestowing  alternative  functionality  on  different 
members of this putative family. Indeed, the putative basic 
minimal spectrin-binding  motif RRRKFH(K/R)  first iden- 
tified in AnkR (Platt et al.,  1993)  is strongly conserved in 
all  known  ankyrin  sequences  irrespective  of  their  tissue 
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(Kordeli et al.,  1995), Drosophila ankyrin (Dubreuil and 
Yu,  1994), and Ank~119 (residues 802-808, Fig.  2).  Also 
supportive of this notion is the marked diversity in alterna- 
tive 5'  and 3'  transcripts being recognized that originate 
from the ANK1 (erythroid) and ANK3 genes despite com- 
plete conservation of the spectrin-binding domain (GaP 
lagher et al., 1992; Birkenmeier et al., 1993; Kordeli et al., 
1995; Peters et al., 1995). 
The structural basis for the failure of AnkGn9 to associ- 
ate with the plasma membrane may be inferred from its 
deduced amino acid sequence. It has been shown that the 
plasma membrane-binding domain of conventional ankyrins 
consists of 22-24 tandemly arrayed repeats that fold into 
four independently folded subdomains of six repeats each 
(Michaely and Bennett, 1993). All four sets of six repeats 
are required for proper folding into a membrane-binding 
globular configuration, with removal of even a single re- 
peat resulting in a 40% loss of a  helicity. All four of the 
six-repeat subdomains  have  also  been implicated in  the 
binding of ankyrin to the anion exchanger (AE1) (Davis et 
al., 1991; Michaely and Bennett, 1993). The loss of the first 
11 repeat units in Ank~119 is therefore anticipated to ren- 
der Ankclt9 unable to bind AE1. It remains undetermined 
whether Ank~tt9 retains binding capacity for other inte- 
gral proteins, such as Na,K-ATPase, which may interact at 
different sites within ankyrin (Morrow et al., 1989; Davis 
and  Bennett,  1990;  Devarajan  et  al.,  1994).  However, 
AnkGt19 almost certainly retains some membrane-binding 
properties, since it appears to be closely associated with 
various  intracellular  membrane  compartments  involved 
with membrane protein biogenesis and polarized assembly. 
The association of AnkGt19 (and 13I~* spectrin) with the 
Golgi is  unexpected  and  provocative, and  suggests  that 
these proteins play a role in the function of this structure. 
Work over the past two decades has established a compre- 
hensive  picture  of many  aspects  of intracellular  vesicle 
trafficking (reviewed in Kreis and Pepperkok, 1994; Mat- 
ter and MeUman,  1994;  Robinson,  1994).  At least three 
classes of transport vesicles are derived from the ER, the 
Golgi, and the plasma  membrane,  respectively. Each  of 
these is characterized not only by specific integral mem- 
brane proteins displaying either apical or basolateral tar- 
geting signals, but also by the assembly of peripheral pro- 
tein coats that tend to be distinct for each vesicle type. These 
coats are believed to control the budding of nascent trans- 
port vesicles and the sorting of specific components to each 
vesicle. The best understood of these coats is the clathrin 
complex characteristic of plasma membrane-derived en- 
dosomes, as well as one class of vesicles budding from the 
trans-Golgi network  (Robinson,  1994).  The  other  two 
classes of vesicles, COP I and COP II, mediate transport 
between the ER and through the Golgi to the trans-Golgi 
network.  COP  I  vesicles  form  by  the  recruitment  of a 
coatamer that consists of at least seven distinct subunits, of 
which ~-COP is one component. These coatamer compo- 
nents have also been recently identified on certain endo- 
somes derived from the plasma membrane, suggesting that 
their function may be more general than first envisioned 
(Whitney et al.,  1995). The assembly of COP I vesicles is 
disrupted by brefeldin A  treatment. The results reported 
here, together with earlier findings that brefeldin A  dis- 
rupts the association of [~IE* spectrin with the  Golgi of 
MDCK cells (Beck et al., 1994), suggest that AnkGlx9 and 
[3IE* spectrin must now be added to the list of coatameric 
proteins that are characteristic of this class of vesicles. 
The functional significance of a 13IE* spectrin and AnkGlt9 
association with components of the ER and Golgi remains 
uncertain.  At  the  plasma  membrane,  the  spectrin-actin 
and ankyrin complex acts to control the lateral organiza- 
tion of integral membrane proteins and to organize mem- 
brane microdomains (reviewed in Bennett and Gilligan, 
1993; Morrow, et al., 1996).  This is probably its most fun- 
damental  role,  rather  than  direct  membrane  support 
(Morrow et al., 1996). By analogy, one would expect that 
the Golgi-13IE* spectrin and AnkG119 complex acts to or- 
ganize microdomains within these membrane compartments 
and perhaps link them to the filamentous actin cytoskele- 
ton  or  to  other  filamentous  components  via  spectrin's 
well-established binding capacities.  Such a linkage, if re- 
quired for polarized vesicular transport, would establish a 
molecular basis for the heretofore unexplained sensitivity 
of polarized vesicular transport to agents that disrupt actin 
filaments (Kelly, 1991). A problem with this hypothesis is 
the relative paucity of Ank6n9 in other epithelia, such as 
enterocytes or hepatocytes (see Fig. 3). Perhaps other iso- 
forms of ankyrin exist in these  lines.  Alternatively, and 
perhaps more likely, the abundance of Ank6119 in differ- 
ent cell types may vary greatly, perhaps reflecting the bal- 
ance between a  cell's use of the trans-Golgi network for 
sorting vs transcytotic pathways, with only those that sort 
predominantly in the trans-Golgi network using AnkGlt9. 
Consonant  with  this  hypothesis would  be  the  predomi- 
nance of this ankyrin in MDCK and kidney cells (in which 
trans-Golgi network sorting pathways predominate, Mat- 
ter and Mellman, 1994)  and the diminution of AnkGlt9 in 
Golgi under confluent [steady-state] conditions in which 
transcytotic  pathways  may  assume  greater  importance 
(Mays et al.,  1995).  It will be of interest to explore these 
novel and testable hypotheses in future studies. 
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